The clinical study on CD19-directed chimeric antigen receptor-modified T cells in patient with Richter Syndrome

被引：1
|
作者：
Xia, Leiming
Chen, Qian
Li, Qiao
Li, Tan
Wang, Yi
Bao, Yangyi
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-CT041
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT041
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The clinical study on treatment of CD19-directed chimeric antigen receptor-modified T cells in a case of refractory Richter syndrome
    Xia, Leiming
    Wang, Yi
    Li, Tan
    Hu, Xueying
    Chen, Qian
    Liu, Liu
    Jiang, Beilei
    Li, Caixin
    Wang, Hua
    Wang, Siying
    Yang, Guanghua
    Bao, Yangyi
    CANCER MEDICINE, 2019, 8 (06): : 2930 - 2941
  • [2] Predominant cerebral cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy
    Hu, Yongxian
    Sun, Jie
    Wu, Zhao
    Yu, Jian
    Cui, Qu
    Pu, Chengfei
    Liang, Bin
    Luo, Yi
    Shi, Jimin
    Jin, Aiyun
    Xiao, Lei
    Huang, He
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2016, 9
  • [3] Predominant cerebral cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy
    Yongxian Hu
    Jie Sun
    Zhao Wu
    Jian Yu
    Qu Cui
    Chengfei Pu
    Bin Liang
    Yi Luo
    Jimin Shi
    Aiyun Jin
    Lei Xiao
    He Huang
    Journal of Hematology & Oncology, 9
  • [4] Advances of CD19-directed chimeric antigen receptor-modified T cells in refractory/relapsed acute lymphoblastic leukemia
    Guoqing Wei
    Lijuan Ding
    Jiasheng Wang
    Yongxian Hu
    He Huang
    Experimental Hematology & Oncology, 6
  • [5] Advances of CD19-directed chimeric antigen receptor-modified T cells in refractory/relapsed acute lymphoblastic leukemia
    Wei, Guoqing
    Ding, Lijuan
    Wang, Jiasheng
    Hu, Yongxian
    Huang, He
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2017, 6
  • [6] Pleural cavity cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy A case report
    Ding, Lijuan
    Hu, Yongxian
    Zhao, Kui
    Wei, Guoqing
    Wu, Wenjun
    Wu, Zhao
    Xiao, Lei
    Huang, He
    MEDICINE, 2018, 97 (07)
  • [7] Chimeric antigen receptor-modified T cells: CD19 and the road beyond
    Salter, Alexander I.
    Pont, Margot J.
    Riddell, Stanley R.
    BLOOD, 2018, 131 (24) : 2621 - 2629
  • [8] Evolution to plasmablastic lymphoma evades CD19-directed chimeric antigen receptor T cells
    Evans, Andrew G.
    Rothberg, Paul G.
    Burack, W. Richard
    Huntington, Scott F.
    Porter, David L.
    Friedberg, Jonathan W.
    Liesveld, Jane L.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 (02) : 205 - 209
  • [9] Chimeric Antigen Receptor-Modified T Cells in CLL
    Yeh, Chi Chun
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (20): : 1937 - 1937
  • [10] Pharmacology of Chimeric Antigen Receptor-Modified T Cells
    Song, Edward Z.
    Milone, Michael C.
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 61, 2021, 2021, 61 : 805 - 829
12345